Your browser doesn't support javascript.
loading
Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer.
Zhou, Junhao; Tian, Hu; Zhi, Xi; Xiao, Zhuoyu; Chen, Taoyi; Yuan, Haoyu; Chen, Qi; Chen, Mingkun; Yang, Jiankun; Zhou, Qizhao; Xue, Kangyi; Guo, Wenbin; Xia, Ming; Bao, Jiming; Yang, Cheng; Duan, Haifeng; Wang, Hongyi; Huang, Zhipeng; Zhu, Ting; Liu, Cundong.
Afiliación
  • Zhou J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Tian H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Zhi X; Department of Urology, The First People's Hospital of Zhaoqing, Zhaoqing, 526020, China.
  • Xiao Z; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Chen T; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Yuan H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Chen Q; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Chen M; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Yang J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Zhou Q; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Xue K; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Guo W; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Xia M; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Bao J; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Yang C; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Duan H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Wang H; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Huang Z; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China.
  • Zhu T; Department of Laboratory Medicine, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, Guangdong, People's Republic of China. zhuting90@foxmail.com.
  • Liu C; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, People's Republic of China. cundongliu@163.com.
Cancer Cell Int ; 21(1): 660, 2021 Dec 11.
Article en En | MEDLINE | ID: mdl-34895217
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Cell Int Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido